Summary
CVS Health Corporation (CVS) reported robust financial performance for the first quarter of 2012, with net revenues increasing by 19.9% to $30.8 billion compared to the same period in 2011. This growth was driven by strong contributions from both the Pharmacy Services and Retail Pharmacy segments. The company's net income attributable to CVS Caremark rose to $776 million, translating to earnings per diluted share of $0.59, an increase from $0.52 in the prior year quarter. The company also highlighted significant improvements in operating cash flow, which surged to $2.8 billion, up from $1.9 billion in the prior year period, reflecting efficient working capital management. Key drivers for the revenue growth included the acquisition of the UAM Medicare PDP Business and new PBM client starts within the Pharmacy Services segment, alongside strong same-store sales and new store openings in the Retail Pharmacy segment. The company also executed a substantial share repurchase program, buying back $810 million worth of stock in the quarter, demonstrating a commitment to returning value to shareholders. Despite some margin compression in the Pharmacy Services segment due to competitive pricing pressures and increased operating costs, overall financial health appears strong with positive trends across key operational and financial metrics.
Financial Highlights
55 data points| Revenue | $30.79B |
| Cost of Revenue | $25.68B |
| Gross Profit | $5.11B |
| Operating Expenses | $3.71B |
| Operating Income | $1.40B |
| Interest Expense | $133.00M |
| Net Income | $772.00M |
| EPS (Basic) | $0.59 |
| EPS (Diluted) | $0.59 |
| Shares Outstanding (Basic) | 1.30B |
| Shares Outstanding (Diluted) | 1.31B |
Key Highlights
- 1Net revenues increased significantly by 19.9% to $30.8 billion, indicating strong top-line growth.
- 2Net income attributable to CVS Caremark rose to $776 million, with diluted EPS reaching $0.59.
- 3Operating cash flow saw a substantial increase of $0.9 billion, reaching $2.8 billion.
- 4Pharmacy Services segment revenue grew 32.3%, driven by new client wins and increased claim volumes.
- 5Retail Pharmacy segment revenue increased by 9.9%, benefiting from strong same-store sales and new store openings.
- 6The company repurchased $810 million of its common stock during the quarter under its $4.0 billion repurchase program.
- 7A change in inventory accounting for prescription drugs in the Retail Pharmacy segment (FIFO to weighted average cost) was implemented, positively impacting gross profit by approximately $30 million.